Neutrophils, a type of white blood cell, play diverse roles in the tumor microenvironment and can impact breast cancer progression and treatment response across different subtypes, namely ER+ (estrogen receptor-positive), HER2+ (human epidermal growth factor receptor 2-positive), and TNBC (triple-negative breast cancer). Here, ESR1 is linked to triple-negative breast carcinoma.